日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cytopenias and infections following ciltacabtagene autoleucel in heavily pretreated relapsed or refractory multiple myeloma

在接受过大量预处理的复发或难治性多发性骨髓瘤患者中,使用ciltacabtagene autoleucel治疗后出现细胞减少症和感染

Dima, Danai; Logue, Jennifer M; Waqar, Syed Hamza Bin; Peres, Lauren C; Colin-Leitzinger, Christelle M; De Avila, Gabriel; Smith, Eric C; Skelson, Lawrence; Matte, Kristy L; Blue, Brandon; Hovanky, Vanna N; Gaballa, Mahmoud; Pasvolsky, Oren; Oswald, Laura B; Fortuna, Gliceida Galarza M; Wagner, Charlotte B; DeJarnette, Shaun; Dillard, Christen; Perna, Fabiana; Mikkilineni, Lekha; Hosoya, Hitomi; Freeman, Ciara L; Shain, Kenneth H; Baz, Rachid C; Grajales-Cruz, Ariel; Puglianini, Omar Castaneda; Alsina, Melissa; Locke, Frederick L; Shune, Leyla O; Sborov, Douglas W; Patel, Krina K; Sidana, Surbhi; Hansen, Doris K

Nivolumab adjuvant to chemo-radiation in localized muscle-invasive urothelial cancer: primary analysis of a multicenter, single-arm, phase II, investigator-initiated trial (NEXT)

纳武利尤单抗辅助化疗放疗治疗局限性肌层浸润性尿路上皮癌:一项多中心、单臂、II期、研究者发起试验(NEXT)的主要分析

Galarza Fortuna, Gliceida M; Grass, Daniel; Maughan, Benjamin L; Jain, Rohit K; Dechet, Christopher; Beck, Julia; Schuetz, Ekke; Sanchez, Alejandro; O'Neil, Brock; Poch, Michael; Li, Roger; Lloyd, Shane; Tward, Jonathan; Phunrab, Tenzin; Hawks, Josiah Lyn; Swami, Umang; Boucher, Kenneth M; Agarwal, Neeraj; Gupta, Sumati

Response to: Comment on "Nivolumab adjuvant to chemo-radiation in localized muscle-invasive urothelial cancer: primary analysis of a multicenter, single-arm, phase II, investigator-initiated trial (NEXT)"

回复:关于“Nivolumab辅助化疗放疗治疗局限性肌层浸润性尿路上皮癌:一项多中心、单臂、II期、研究者发起试验(NEXT)的主要分析”的评论

Galarza Fortuna, Gliceida M; Swami, Umang; Gupta, Sumati

Treatment and Attrition Trends for Metastatic Clear Cell Renal Cell Carcinoma in the US

美国转移性透明细胞肾细胞癌的治疗和流失趋势

Ozay, Zeynep Irem; Jo, Yeonjung; Galarza Fortuna, Gliceida; Hage Chehade, Chadi; Gebrael, Georges; Ostrowski, Micah; Sayegh, Nicolas; Anderson, Ethan; Jaime-Casas, Salvador; Zugman, Miguel; Mathew Thomas, Vinay; Maughan, Benjamin L; Agarwal, Neeraj; Pal, Sumanta K; Swami, Umang

Safety and efficacy of BCMA-directed chimeric antigen receptor T-cell therapy for the treatment of plasma cell leukemia

BCMA靶向嵌合抗原受体T细胞疗法治疗浆细胞白血病的安全性和有效性

Galarza Fortuna, Gliceida M; Peres, Lauren; Nazarenko, Elena; De Menezes Silva Corraes, Andre; Hovanky, Vanna N; Shune, Leyla; McGuirk, Joseph; De Avilla, Gabriel; Khouri, Jack; Dima, Danai; Gaballa, Mahmoud; Dhakal, Binod; Forsberg, Peter; Godara, Amandeep; Afrough, Aimaz; Anderson, Larry D Jr; Herr, Megan M; Davis, James A; Mann, Hashim; Purvey, Sneha; Clark, William; Htut, Myo; Beitinjaneh, Amer; Pereira, Denise L; Kocoglu, Mehmet H; Ferreri, Christopher James; Atrash, Shebli; Voorhees, Peter M; Rossi, Adriana; Shambavi, Richard; Hashmi, Hamza; Patel, Krina; Sidana, Surbhi; Lin, Yi; Hansen, Doris K; Sborov, Douglas W

The past, present, and future of myeloma staging and risk prognostication

多发性骨髓瘤分期和风险预后的过去、现在和未来

Baysal, Mehmet; Julian, Kelley; Sborov, Douglas; Godara, Amandeep; McClune, Brian; Lohr, Jens G; Fortuna, Gliceida Galarza; Mohyuddin, Ghulam Rehman

First-Line Ipilimumab with Nivolumab versus Immune Checkpoint Inhibitors with Tyrosine Kinase Inhibitors in Patients with Intermediate- or Poor-Risk Metastatic Clear Cell Renal Cell Carcinoma

一线伊匹木单抗联合纳武利尤单抗对比免疫检查点抑制剂联合酪氨酸激酶抑制剂治疗中危或高危转移性透明细胞肾细胞癌患者

Ostrowski, Micah; Jo, Yeonjung; Gebrael, Georges; Chehade, Chadi Hage; Ozay, Zeynep Irem; Nordblad, Blake; Srivastava, Ayana; Garg, Diya; Ji, Richard; Fortuna, Gliceida Galarza; Thomas, Vinay Mathew; Chigarira, Beverly; Anderson, Ethan; Agarwal, Neeraj; Maughan, Benjamin L; Swami, Umang

Alterations in chromosome 1q in multiple myeloma randomized clinical trials: a systematic review

多发性骨髓瘤随机临床试验中1q染色体改变:系统评价

Neupane, Karun; Fortuna, Gliceida Galarza; Dahal, Riyasha; Schmidt, Timothy; Fonseca, Rafael; Chakraborty, Rajshekhar; Koehn, Kelly Ann; Mohan, Meera; Mian, Hira; Costa, Luciano J; Sborov, Douglas; Mohyuddin, Ghulam Rehman

Immune effector cell-associated enterocolitis following chimeric antigen receptor T-cell therapy in multiple myeloma

多发性骨髓瘤嵌合抗原受体T细胞疗法后免疫效应细胞相关性肠炎

Fortuna, Gliceida Galarza; Banerjee, Rahul; Savid-Frontera, Constanza; Song, Jinming; Morán-Segura, Carlos M; Nguyen, Jonathan V; Lekakis, Lazaros; Fernandez-Pol, Sebastian; Samraj, Annie N; Naresh, Kikkeri N; Vazquez-Martinez, Mariola; Baz, Rachid C; Spiegel, Jay Y; Mikkilineni, Lekha; Gubatan, John M; Sidana, Surbhi; de Menezes Silva Corraes, Andre; Kalariya, Nilesh M; Patel, Krina K; Shim, Kevin G; Fonseca, Rafael; Ferreri, Christopher; Voorhees, Peter M; Richard, Shambavi; Valdes, Cesar Rodriguez; Sireesha Asoori; Wolf, Jeffrey L; Cowan, Andrew J; Sborov, Douglas W; Locke, Frederick L; Lin, Yi; Wang, Yinghong; Hansen, Doris K

Treatment Patterns and Attrition With Lines of Therapy for Advanced Urothelial Carcinoma in the US

美国晚期尿路上皮癌治疗模式及治疗线流失情况

Mathew Thomas, Vinay; Jo, Yeonjung; Tripathi, Nishita; Roy, Soumyajit; Chigarira, Beverly; Narang, Arshit; Gebrael, Georges; Hage Chehade, Chadi; Sayegh, Nicolas; Galarza Fortuna, Gliceida; Ji, Richard; Campbell, Patrick; Li, Haoran; Agarwal, Neeraj; Gupta, Sumati; Swami, Umang